Banook Group
Isabelle Giuliani has a diverse work experience spanning over two decades. Isabelle began their career in 1998 as a Project Leader at Sanofi Diagnostics Pasteur, where they worked for a year. Isabelle then joined Bio-Rad Laboratories in 2000 as an R&D Project Leader in the Cardiovascular division for three years. Isabelle continued their journey at Bio-Rad Laboratories and became the R&D Group Manager in the Cardiovascular Business Unit from 2003 to 2008. Isabelle later transitioned to the role of Business Unit Project Manager from 2008 to 2011. Isabelle then moved to Genclis SAS in 2011 as a Cancer Test Development Manager for two years. In 2013, they joined Banook Group as a Clinical Project Manager, responsible for managing ECG central reading activities across various therapeutic areas. At Banook Group, Isabelle currently holds the position of Clinical Study Management Lead, where they have overall responsibility for study management in clinical trials across multiple therapeutic areas.
Isabelle Giuliani's education history begins with their studies at Groupe IFG from 2009 to 2010, where they focused on Project Management. Prior to that, they obtained a Master's Degree in Health Engineering / Biotechnology from Ingénieur Universitaire, attending from 1993 to 1999. Lastly, a specific start and end year is not provided, but Isabelle attended Faculté de Pharmacie Montpellier, although details regarding their degree or field of study are not specified.
Banook Group
Banook Group is one of the few established international providers capable of supplying cardiac safety, central imaging and endpoint adjudication services to pharmaceutical, medical device and biotech companies, CROs and nonprofit organizations. Its mission is to help its clients invent tomorrow’s healthcare, using qualitative, reliable and innovative solutions in early to late stage clinical trials and ultimately to bring new solutions to the market for the benefit of patients worldwide. Its medical and regulatory expertise, quality-driven approach and team availability make the Banook Group a key player for clinical trial services. Founded in 1999, Banook Group is a non-listed family company. Financially stable and strong, the group operates on an international scale, maintaining offices at its headquarters in Nancy (France) and in the United States (Mystic, CT). To learn more about the Banook Group and its subsidiaries (formerly CardiaBase, Banook Central Imaging and Banook Inc.), please visit our new website www.banookgroup.com